Ozempic Maker to Study Its Effect on Alcohol Consumption
Novo Nordisk, the maker of Ozempic, plans to study the drug’s effect on alcohol consumption.
GLP-1 Drugs Used to Reduce Cancer, Fight Dementia
GLP-1 agonists such as Ozempic and Wegovy are being tested for their ability to impact cancer rates and slow dementia.
More Studies Show Positive Impacts From GLP-1 Agonist Drugs
A new survey from National Geographic explores many positive outcomes of recent trials with GLP-1 agonist drugs.
Drug Companies “Apathetic” About Testing GLP-1 Drugs to Treat Substance Use Disorders
Early studies of GLP-1 drugs for substance abuse treatment show promise, but drug companies are slow to fund research.
Liraglutide and Semaglutide Show Promise in the Treatment of Opioid Use Disorder and Alcohol Use Disorder
New research indicates that liraglutide, semaglutide, and similar GLP-1 drugs may be effective at reducing cravings for opioids and alcohol.
People Who Stop Taking GLP-1 Drugs Such As Ozempic and Wegovy Rapidly Gain Back Weight
New reporting documents the weight gain when people stop taking GLP-1 drugs such as Ozempic and Wegovy.